Alfonso Berrocal

A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)

Carmen Balañá, María Ángeles Vaz Salgado, Juan Manuel Sepúlveda-Sánchez et al. · Neuro-Oncology · 2020 · 107 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Extended-schedule dose-dense temozolomide in refractory gliomas

Alfonso Berrocal, Pedro Pérez Segura, Carmen Balañá et al. · Journal of Neuro-Oncology · 2009 · 61 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis

Anthony D Puopolo, Judith A. Boice, James Fidelholtz et al. · Osteoarthritis and Cartilage · 2007 · 59 citations

Medicine, Pharmacology, Pharmacotherapy +7

Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer

Joan Carles, Emilio Esteban, Albert Font et al. · Annals of Oncology · 2007 · 58 citations · Full text

Medicine, Oncology, Urology +15

A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy

Sarah A. Weiss, Mario Sznol, Montaser Shaheen et al. · Clinical Cancer Research · 2023 · 58 citations · Full text

Medicine, Oncology, Pharmacology +17